Identification of these unknown factor(s) will be pursued in a further study, and elucidation of the Parkin activation mechanism, including phosphorylation of the Ubl domain, and role of Parkin phosphorylation in neuronal activities will contribute to the identification of a potential therapeutic target in PD pathogenesis. This evidence concerns the gene PRKN and Parkinson disease.